Your browser doesn't support javascript.
loading
Defining a standard set of patient-centered outcomes for men with localized prostate cancer.
Martin, Neil E; Massey, Laura; Stowell, Caleb; Bangma, Chris; Briganti, Alberto; Bill-Axelson, Anna; Blute, Michael; Catto, James; Chen, Ronald C; D'Amico, Anthony V; Feick, Günter; Fitzpatrick, John M; Frank, Steven J; Froehner, Michael; Frydenberg, Mark; Glaser, Adam; Graefen, Markus; Hamstra, Daniel; Kibel, Adam; Mendenhall, Nancy; Moretti, Kim; Ramon, Jacob; Roos, Ian; Sandler, Howard; Sullivan, Francis J; Swanson, David; Tewari, Ashutosh; Vickers, Andrew; Wiegel, Thomas; Huland, Hartwig.
Affiliation
  • Martin NE; International Consortium for Health Outcomes Measurement, Cambridge, MA, USA; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: nmartin@lroc.harvard.edu.
  • Massey L; International Consortium for Health Outcomes Measurement, Cambridge, MA, USA.
  • Stowell C; International Consortium for Health Outcomes Measurement, Cambridge, MA, USA.
  • Bangma C; Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Briganti A; Prostate Cancer Research Programme at the Urological Research Institute, Department of Urology, Vita-Salute San Raffaele University Hospital, Milan, Italy.
  • Bill-Axelson A; Department of Surgical Sciences, Department of Urology, Uppsala University Hospital and National Prostate Cancer Register of Sweden, Uppsala, Sweden.
  • Blute M; Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Catto J; University of Sheffield Academic Urology Unit and Academic Unit of Molecular Oncology, CR-UK/YCR, Sheffield Cancer Research Centre, University of Sheffield Medical School, Sheffield, UK.
  • Chen RC; Department of Radiation Oncology, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • D'Amico AV; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Feick G; Bundesverband Prostatakrebs Selbsthilfe, Pohlheim, Germany.
  • Fitzpatrick JM; Irish Cancer Society, Dublin, Ireland.
  • Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Froehner M; Department of Urology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Frydenberg M; Department of Surgery, Monash University, Victoria, Australia.
  • Glaser A; Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK.
  • Graefen M; Martini-Klinik at University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Hamstra D; Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI, USA.
  • Kibel A; Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Mendenhall N; University of Florida Proton Therapy Institute, Jacksonville, FL, USA.
  • Moretti K; South Australian Prostate Cancer Clinical Outcomes Collaborative, Repatriation General Hospital, Daw Park, South Australia, Australia.
  • Ramon J; Department of Urology and Uro-Oncology, Chaim Sheba Medical Center at Tel Hashomer, Tel Hashomer, Israel.
  • Roos I; Cancer Voices Australia, Melbourne, Victoria, Australia.
  • Sandler H; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Sullivan FJ; Prostate Cancer Institute, NUI Galway, Galway, Ireland.
  • Swanson D; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tewari A; Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
  • Vickers A; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Wiegel T; Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany.
  • Huland H; Martini-Klinik at University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Eur Urol ; 67(3): 460-7, 2015 Mar.
Article in En | MEDLINE | ID: mdl-25234359
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Health Status / Health Status Indicators / Process Assessment, Health Care / Patient-Centered Care / Quality Indicators, Health Care / Medical Oncology Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude / Patient_preference Limits: Humans / Male Language: En Journal: Eur Urol Year: 2015 Document type: Article Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Health Status / Health Status Indicators / Process Assessment, Health Care / Patient-Centered Care / Quality Indicators, Health Care / Medical Oncology Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude / Patient_preference Limits: Humans / Male Language: En Journal: Eur Urol Year: 2015 Document type: Article Country of publication: Switzerland